UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$494M |
| 2 |
Johnson & Johnson
JNJ
|
+$466M |
| 3 |
Procter & Gamble
PG
|
+$299M |
| 4 |
Amazon
AMZN
|
+$285M |
| 5 |
Advanced Micro Devices
AMD
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$510M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$315M |
| 4 |
Intel
INTC
|
+$227M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.22% |
| 2 | Healthcare | 12.65% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Financials | 11.23% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
AdvanSix
ASIX
$444M
| $1.09M | ﹤0.01% |
36,308
| – | – |
|
1927
Winmark
WINA
$1.32B
| $1.09M | ﹤0.01% |
2,604
+1,555
| +148% | +$654K |
|
1928
Janus International
JBI
$757M
| $1.09M | ﹤0.01% |
83,284
-1,016
| -1% | -$10.8K |
|
|
AKRO
1929
DELISTED
Akero Therapeutics
AKRO
| $1.09M | ﹤0.01% |
46,539
| – | – |
|
1930
Ecovyst
ECVT
$1.14B
| $1.08M | ﹤0.01% |
111,027
+2,291
| +2% | +$21.8K |
|
|
CIM
1931
Chimera Investment
CIM
$1B
| $1.08M | ﹤0.01% |
72,036
| – | – |
|
1932
Amerant Bancorp
AMTB
$1.13B
| $1.08M | ﹤0.01% |
43,837
| – | – |
|
|
MODN
1933
DELISTED
MODEL N, INC.
MODN
| $1.08M | ﹤0.01% |
39,976
+789
| +2% | +$19K |
|
1934
Alignment Healthcare
ALHC
$2.98B
| $1.08M | ﹤0.01% |
124,913
+11,646
| +10% | +$85.2K |
|
1935
ACM Research
ACMR
$5.79B
| $1.07M | ﹤0.01% |
54,744
-8,591
| -14% | -$150K |
|
|
EFC
1936
Ellington Financial
EFC
$1.71B
| $1.07M | ﹤0.01% |
84,007
-805
| -0.9% | -$10.2K |
|
1937
Scholar Rock
SRRK
$6.44B
| $1.07M | ﹤0.01% |
56,778
+5,376
| +10% | +$66.8K |
|
1938
ChargePoint
CHPT
$161M
| $1.07M | ﹤0.01% |
22,777
+1,426
| +7% | +$79.8K |
|
1939
AMC Entertainment Holdings
AMC
$2.31B
| $1.06M | ﹤0.01% |
173,793
+41,450
| +31% | +$336K |
|
1940
Unitil
UTL
$980M
| $1.06M | ﹤0.01% |
20,203
+4,487
| +29% | +$217K |
|
1941
Agios Pharmaceuticals
AGIO
$1.93B
| $1.06M | ﹤0.01% |
47,461
| – | – |
|
1942
Weis Markets
WMK
$1.86B
| $1.06M | ﹤0.01% |
16,506
-2,824
| -15% | -$180K |
|
|
XRN
1943
Chiron Real Estate Inc
XRN
$477M
| $1.06M | ﹤0.01% |
19,022
| – | – |
|
|
IAS
1944
DELISTED
Integral Ad Science
IAS
| $1.06M | ﹤0.01% |
73,349
+49,595
| +209% | +$664K |
|
|
EVBG
1945
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.05M | ﹤0.01% |
43,320
| – | – |
|
|
RVNC
1946
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.05M | ﹤0.01% |
119,361
+8,686
| +8% | +$71.2K |
|
1947
Alpha and Omega Semiconductor
AOSL
$1.08B
| $1.05M | ﹤0.01% |
40,245
| – | – |
|
1948
Chefs' Warehouse
CHEF
$4.5B
| $1.05M | ﹤0.01% |
35,609
+1,657
| +5% | +$40K |
|
1949
Enviri
NVRI
$620M
| $1.05M | ﹤0.01% |
116,247
-32,257
| -22% | -$220K |
|
1950
Compass Minerals
CMP
$1.15B
| $1.04M | ﹤0.01% |
41,250
+581
| +1% | +$14.8K |
|
Similar funds
UBS AM's Q4 2023 Portfolio in Review
As of Q4 2023, UBS AM held 2,644 positions worth $254B, up 14% from $223B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM's Q4 2023 filing shows 62 new, 1,338 increased, 675 reduced and 106 closed positions. Its largest new stake was Veralto: 1,187,566 shares worth $97.7M. The largest sale was VMware, Inc, an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- UBS AM's largest Q4 2023 buy was Veralto: 1,187,566 shares worth $97.7M.
- UBS AM added most to Broadcom in Q4 2023, an estimated $494M increase.
- UBS AM's biggest Q4 2023 reduction was Microsoft, cutting an estimated $315M.
- UBS AM fully exited VMware, Inc in Q4 2023, selling an estimated $510M.
- UBS AM's ten largest holdings make up 26% of its $254B portfolio in Q4 2023.
- UBS AM opened 62 new positions and closed 106 in Q4 2023.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $254B.
Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.